Summit Therapeutics
biopharmaceutical company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 6 annual filings
Revenue
$0.00
Net Income
-$1.08B
Assets
$751.18M
EPS (diluted)
$-1.44
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2024-12-31 · accession
0001599298-25-000048Summit Therapeutics
Summary
Summit Therapeutics is a public company[1].
Key Facts
- Summit Therapeutics's field of work was biopharmaceutical[2].
- Summit Therapeutics is in the country of GB[3].
- Summit Therapeutics's instance of is recorded as public company[4].
- Summit Therapeutics's headquarters location is recorded as Menlo Park[5].
- Summit Therapeutics's stock exchange is recorded as Nasdaq[6].
- 2003 marks the founding of Summit Therapeutics[7].
- Summit Therapeutics's official website is recorded as https://www.summittxinc.com/[8].
- Summit Therapeutics's legal form is recorded as B6ES[9].
- Summit Therapeutics's street address is recorded as 136A EASTERN AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM, OX14 4SB[10].
Body
Founding
2003 marks the founding of Summit Therapeutics[7].
Operations
Summit Therapeutics's headquarters location is recorded as Menlo Park[5].
Industry
Summit Therapeutics's field of work was biopharmaceutical[2].
Ownership
Summit Therapeutics's stock exchange is recorded as Nasdaq[6].